Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
3
Neutral
7
Bullish
4
Bearish
34
Neutral
7
Bullish
5
Bearish
31
Neutral
0
Bullish
1
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Market Cap
₹ 1,311 Cr
P/E
21.32
Sigachi Industries Ltd is a prominent global manufacturer of pharmaceutical excipients and active pharmaceutical ingredients (APIs).
Recently, the company has enhanced its manufacturing capabilities by fast-tracking the expansion of its Dahej facility, demonstrating commitment to meet increasing global demand for MCC.
Strategically, Sigachi has established a joint venture with Saudi National Projects Investment Limited, further expanding its presence in the Middle East markets.
The recent unfortunate fire incident at the Pashamylaram unit has accelerated operational and cultural transformations, enhancing resilience and safety protocols.
Moving forward, Sigachi Industries continues to focus on high-value product portfolio optimization and operational efficiencies to drive future growth.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
1,311 Cr
High Risk
21.3
30.8
2.7
2.6
59.50
30.54
Sales CAGR
1Y
22.38%
3Y
17.81%
5Y
24.05%
10Y
20.11%
Profit CAGR
1Y
23.03%
3Y
7.82%
5Y
18.47%
10Y
33.86%
ROE
TTM
12.11%
3Y
10.54%
5Y
12.67%
10Y
14.48%
ROCE
TTM
12.71%
3Y
14.60%
5Y
16.90%
10Y
19.65%
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
180.95 | 1,337 Cr | 9.70 | 5.29 | 0.00 | 49.16 | 66.08 | 47.21 | |
197.50 | 1,334 Cr | 30.49 | 5.27 | 1.24 | 17.30 | 21.58 | 20.71 | |
34.47 | 1,311 Cr | 21.32 | 2.58 | 0.29 | 12.11 | 12.71 | -6.32 | |
413.20 | 1,297 Cr | 25.34 | 2.67 | 0.24 | 10.52 | 10.52 | 5.46 | |
930.00 | 980 Cr | 19.97 | 3.39 | 0.00 | 16.91 | 18.84 | 10.27 | |
102.65 | 965 Cr | — | 2.78 | 0.48 | -7.10 | -3.47 | -4.63 | |
415.05 | 934 Cr | 47.75 | 3.08 | 0.00 | 6.43 | 8.43 | 4.35 |
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
